Delayed
OTC Markets
03:13:11 2024-07-15 pm EDT
|
5-day change
|
1st Jan Change
|
0.0519
USD
|
-0.19%
|
|
+3.80%
|
+26.59%
|
Fiscal Period: October |
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
29.91
|
34.11
|
22.31
|
3.7
|
Enterprise Value (EV)
1 |
27.48
|
33.52
|
22.16
|
3.699
|
P/E ratio
|
-10.1
x
|
-4.75
x
|
-1.72
x
|
-0.44
x
|
Yield
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
EV / FCF
|
-452,322,377
x
|
-12,388,775
x
|
-30,122,929
x
|
911,608
x
|
FCF Yield
|
-0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
3.25
x
|
4.17
x
|
-28.8
x
|
-1.08
x
|
Nbr of stocks (in thousands)
|
71,203
|
92,187
|
108,813
|
148,014
|
Reference price
2 |
0.4200
|
0.3700
|
0.2050
|
0.0250
|
Announcement Date
|
3/1/21
|
2/28/22
|
3/3/23
|
7/9/24
|
Fiscal Period: October |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-0.1833
|
-1.009
|
-5.979
|
-3.803
|
-2.403
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-0.2169
|
-1.103
|
-6.458
|
-11.73
|
-7.687
|
Net income
1 |
-0.2301
|
-1.174
|
-6.458
|
-11.73
|
-7.687
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-0.0222
|
-0.0416
|
-0.0779
|
-0.1194
|
-0.0573
|
Free Cash Flow
|
-
|
-0.0608
|
-2.705
|
-0.7358
|
4.058
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/21
|
3/1/21
|
2/28/22
|
3/3/23
|
7/9/24
|
Fiscal Period: October |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
0.23
|
2.42
|
0.59
|
0.14
|
0
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-0.06
|
-2.71
|
-0.74
|
4.06
|
ROE (net income / shareholders' equity)
|
-
|
-22.6%
|
-72.8%
|
-317%
|
371%
|
ROA (Net income/ Total Assets)
|
-
|
-11.7%
|
-39.4%
|
-50.7%
|
-307%
|
Assets
1 |
-
|
10.02
|
16.38
|
23.11
|
2.506
|
Book Value Per Share
2 |
0.0200
|
0.1300
|
0.0900
|
-0.0100
|
-0.0200
|
Cash Flow per Share
2 |
0.0200
|
0.0300
|
0.0100
|
0
|
0
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/1/21
|
3/1/21
|
2/28/22
|
3/3/23
|
7/9/24
|
|
1st Jan change
|
Capi.
|
---|
| +21.85% | 127B | | +24.77% | 117B | | +26.87% | 27.67B | | -18.51% | 20.33B | | -15.36% | 16.79B | | -17.79% | 15.63B | | +13.42% | 14.84B | | -47.10% | 14.65B | | +57.60% | 14.43B |
Bio Therapeutic Drugs
|